Metropolitan Life Insurance CO Citius Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$1.08 - $1.65 $7,805 - $11,924
7,227 New
7,227 $8,000
Q3 2021

Nov 15, 2021
SELL
$1.74 - $2.6 $68,133 - $101,808
-39,157 Closed
0 $0
Q2 2021

Jun 21, 2023
BUY
$1.51 - $4.23 $59,127 - $165,634
39,157 New
39,157 $136,000
Q2 2021

Mar 30, 2023
BUY
$1.51 - $4.23 $59,127 - $165,634
39,157 New
39,157 $136,000
Q2 2021

Aug 16, 2021
BUY
$1.51 - $4.23 $59,127 - $165,634
39,157 New
39,157 $136,000

Others Institutions Holding CTXR

# of Institutions
61
Shares Held
23.7M
Call Options Held
83.1K
Put Options Held
32.1K
View Full List

About Citius Pharmaceuticals, Inc.

CTXR Quotes by TradingView
  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $376M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email